B Halioua1, B Cribier2, M Frey3, J Tan4. 1. Institut Alfred Fournier, Paris, France. 2. Clinique Dermatologique, Université de Strasbourg et Hôpitaux Universitaires de Strasbourg, Strasbourg, France. 3. Department of Psychology, University of Windsor, Windsor, ON, Canada. 4. University of Western Ontario and Windsor Clinical Research Inc, Windsor, ON, Canada.
Abstract
BACKGROUND: Rosacea is a chronic facial disease that may lead to feelings of stigmatization, which can negatively impact psychological and social well-being. OBJECTIVE: The aim of this study was to evaluate different aspects of rosacea that could contribute to feelings of stigmatization. METHODS: An online survey of a representative sample of the adult population in the UK, France, Germany and US was conducted to identify patients with rosacea based on presence of three or more clinical features. RESULTS: Among the patients who completed the survey (n = 807), mean age at first sign/symptom of rosacea was 31.3 ± 14.5 years; mean duration of disease was 102 ± 119 months. One-third of patients reported feelings of stigmatization (FS; n = 275). Male patients were more likely to experience FS (49% vs. 37.2% in non-FS population; P = 0.0037). Those with FS were more likely to avoid social situations (54.2% vs. 2.0%, P < 1.00E-10 ) and had a higher rate of depression (36.7% vs. 21.1%, P < 1.00E-10 ). CONCLUSIONS: Stigmatization is important in the daily lives of those with rosacea and should be taken into consideration in the management of these patients.
BACKGROUND:Rosacea is a chronic facial disease that may lead to feelings of stigmatization, which can negatively impact psychological and social well-being. OBJECTIVE: The aim of this study was to evaluate different aspects of rosacea that could contribute to feelings of stigmatization. METHODS: An online survey of a representative sample of the adult population in the UK, France, Germany and US was conducted to identify patients with rosacea based on presence of three or more clinical features. RESULTS: Among the patients who completed the survey (n = 807), mean age at first sign/symptom of rosacea was 31.3 ± 14.5 years; mean duration of disease was 102 ± 119 months. One-third of patients reported feelings of stigmatization (FS; n = 275). Male patients were more likely to experience FS (49% vs. 37.2% in non-FS population; P = 0.0037). Those with FS were more likely to avoid social situations (54.2% vs. 2.0%, P < 1.00E-10 ) and had a higher rate of depression (36.7% vs. 21.1%, P < 1.00E-10 ). CONCLUSIONS: Stigmatization is important in the daily lives of those with rosacea and should be taken into consideration in the management of these patients.
Authors: Esther J van Zuuren; Bernd W M Arents; Mireille M D van der Linden; Sofieke Vermeulen; Zbys Fedorowicz; Jerry Tan Journal: Am J Clin Dermatol Date: 2021-03-23 Impact factor: 7.403
Authors: Carmela Mento; Amelia Rizzo; Maria Rosaria Anna Muscatello; Rocco Antonio Zoccali; Antonio Bruno Journal: Int J Psychol Res (Medellin) Date: 2020 Jan-Jul